Why is Core Scientific stock falling today? Seller dominance and next support levels to watch

Why is Core Scientific stock falling today? Seller dominance and next support levels to watch
Core Scientific drops 4.62% to $20.04

Core Scientific (CORZ) stock is trading at $20.04 after falling 4.62% today. The move places it below its main short- and medium-term moving averages, with price remaining supported above longer-term trend lines.

CORZ price prediction
24H -0.08%
$12.71
48H 0.31%
$12.76
7D 1.34%
$12.89
1M -22.8%
$9.82
3M -45.99%
$6.87
6M -48.35%
$6.57
12M -44.73%
$7.03
Current price: $12.72 0.9589 8.15%
Closed 11/09
Daily range 11.62 Arrow from to Icon 12.78
Weekly range 10.61 Arrow from to Icon 14.23
Loading...

Highlights

  • Core Scientific secured a long-term partnership to provide AMD with over 500 megawatts of U.S. data-center capacity starting in 2027, supporting future revenue visibility.
  • This agreement signals a strategic shift for Core Scientific by landing a major named client and unlocking expandable infrastructure commitments up to 2.5 gigawatts.
  • Shares of Core Scientific trade under persistent selling pressure near $20.04 with bearish momentum, likely remaining volatile between $18.65 to $21.43 and a high probability of further downside.

Muted market response as AMD partnership reshapes strategy

Core Scientific disclosed on July 28 a major infrastructure partnership with Advanced Micro Devices, granting AMD’s ecosystem access to more than 500 megawatts of U.S. data-center capacity beginning in 2027, with provisions to expand this to 2.5 gigawatts, according to Insider Monkey. This long-term arrangement marks a significant shift in Core Scientific's commercial strategy, as it secures a large-scale, named client and opens a material pipeline of future data-center utilization. While this agreement signals anticipated revenue opportunities from 2027 onward, the announcement has been met with muted immediate market response, as price action has remained under broader selling pressure.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Oversold signals and intraday seller dominance as resistance holds

On the technical front, CORZ/USD is trading below both its MA-20 and MA-50 on the hourly chart, while holding above the MA-200 on the daily timeframe. The Ichimoku Kijun at $21.55 acts as immediate resistance for the stock. Momentum indicators reinforce a weak profile: MACD shows Sell, ADX is Neutral, and both RSI at 26.77 and Stoch RSI are in oversold territory, with CCI also oversold. Bull/Bear Power highlights strong seller dominance intraday, while the Awesome Oscillator signals Sell, reflecting continued downward momentum.

Rangebound outlook as downside risk remains dominant

In the near term, CORZ is expected to trade within the $18.65 to $21.43 range, as probability models suggest only a 22% chance of an upward move versus a 78% likelihood of further declines. The base scenario points to consolidation between these support and resistance levels. A bullish outcome would require a sustained break above $21.55, while failure to hold $18.65 support could open the door to further downside in the days ahead.

Anton Kharitonov, expert at Traders Union, remains cautious on Core Scientific. He sees that while the AMD partnership provides long-term potential, near-term price action reflects ongoing selling pressure and weak momentum. Technicals suggest support at $18.65 and resistance at $21.55, with a high likelihood of further declines if support breaks. "Until the price can reclaim and hold above $21.55, the risk of additional downside remains dominant for CORZ."

Previously it was reported that Core Scientific faced prevailing technical and momentum challenges, maintaining a bearish to sideways bias amid industry headwinds. The current analysis further reinforces this outlook with updated technical evidence and highlights $18.65 as a critical support level to monitor for potential continued weakness in the near term.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.